PyInvesting

Market research

002019.SHE Yifan Pharmaceutical Co., Ltd

SHE CNY Healthcare

Latest close

9.23 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
11B
P/E ratio
37.32
Analyst target
12
Dividend yield
1.0%
Beta
0.47

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Yifan Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 18.4% below its 200 day moving average.

From a valuation standpoint, the stock is 52.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.6.

Yifan Pharmaceutical Co., Ltd's total revenue sank by 9.5% to $1B since the same quarter in the previous year.

Its net income has dropped by 64.6% to $57M since the same quarter in the previous year.

Finally, its free cash flow fell by 236.5% to $-210M since the same quarter in the previous year.

Based on the above factors, Yifan Pharmaceutical Co., Ltd gets an overall score of 1/5.